Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-05Clinical Trial Update: Azacitidine and Entinostat in Treating Patients With Stage I Non-Small Cell Lung Cancer That Has Been Removed By Surgery [Phase 2]
Phase 2 trial investigating azacitidine with entinostat in patients with Stage I non-small cell lung cancer after surgical removal; the stud…
-
CLINICAL_TRIALS withdrawal · 2019-02-04Clinical Trial Update: A Study Comparing AC0010 and Chemotherapy in Patients With Advanced NSCLC Who Have Progressed Following Prior EGFR TKI [Phase 3]
The Phase 3 trial comparing AC0010 to standard chemotherapy in advanced non-small cell lung cancer after progression on EGFR inhibitors has …
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Phase II Study of Itraconazole and Pemetrexed in Patients With Previously Treated Non-Squamous NSCLC [Phase 2]
Phase II study evaluating itraconazole in combination with pemetrexed in patients with previously treated non-squamous non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Preliminary Evaluation of Safety and Efficacy by [14C] AC0010 Trail and Subsequent AC0010 Treatment [Phase 1]
Phase 1 trial evaluating safety and preliminary efficacy of AC0010 in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Efficacy and Safety of Momelotinib Combined With Trametinib in Adults With Metastatic KRAS-mutated Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Platinum-Based Chemotherapy Preceded by a Dose-finding Lead-in Phase [Phase 1]
A terminated Phase 1 trial assessing the efficacy and safety of combining momelotinib with trametinib in adults with relapsed/metastatic KRA…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2019-02-01Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of SH-1028 in Locally Advanced or Metastatic NSCLC [Phase 2]
A Phase 2 clinical trial evaluating the safety and efficacy of SH-1028 in locally advanced or metastatic non-small cell lung cancer is ongoi…
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Erlotinib and Momelotinib for the Treatment of Epidermal Growth Factor Receptor (EGFR) Mutated EGFR Tyrosine Kinase Inhibitor (TKI) Naive Metastatic Non-Small Cell Lung Cancer (NSCLC) [Phase 1]
Phase 1 trial evaluating erlotinib and momelotinib for EGFR-mutated, EGFR TKI-naive metastatic non-small cell lung cancer has been terminate…
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases [Phase 3]
A Phase 3 trial in non-squamous non-small cell lung cancer with brain metastases has been terminated; no results are provided in this update…
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial of GSK1572932A as adjuvant therapy in non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: A Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial assessing MEDI4736 (durvalumab) after concurrent chemoradiation in stage III unresectable non-small cell lung cancer has compl…
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Early Stereotactic Body Radiation Therapy to the Primary Tumor in Advanced Non-small Cell Lung Cancer [Phase 3]
This Phase 3 clinical trial update examines the efficacy of an epidermal growth factor receptor tyrosine kinase inhibitor used with early st…
-
CLINICAL_TRIALS research · 2019-01-30Clinical Trial Update: Anlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung Cancer [NA]
Clinical trial update on combining anlotinib hydrochloride with EGFR TKIs for advanced non-small cell lung cancer; phase and status are not …
-
CLINICAL_TRIALS trial_result · 2019-01-28Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of SH-1028 in Patients With Advanced NSCLC [Phase 1]
This Phase 1 trial update reports on the safety, tolerability, and pharmacokinetics of SH-1028 in patients with advanced non-small cell lung…
-
CLINICAL_TRIALS research · 2019-01-25Clinical Trial Update: The Predictive Role of Programmed Death Ligand 1 (PD-L1) and Neutrophil to Lymphocyte Ratio (NLR) in Non-Small Cell Lung Cancer (NSCLC)
This clinical trial update discusses the potential predictive role of PD-L1 expression and neutrophil-to-lymphocyte ratio in selecting patie…
-
CLINICAL_TRIALS withdrawal · 2019-01-24Clinical Trial Update: Study of Proteins in Tumor Samples From Patients With Non-Small Cell Lung Cancer
The trial studying proteins in tumor samples from patients with non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: The Efficacy and Drug Resistance Molecular Biology of Apatinib Combined With EGFR-TK1 Treated for Advanced Slow-progressed Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating the efficacy and resistance mechanisms of combining apatinib with an EGFR tyrosine kinase inhibitor for advanced sl…
-
CLINICAL_TRIALS research · 2019-01-22Clinical Trial Update: Cancer Panel From Blood of Lung Cancer Patients
Update on a blood-based cancer panel study in patients with non-small cell lung cancer (metastatic or recurrent) conducted by Seoul National…
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: A Study of Famitinib Plus Docetaxel in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC) [Phase 1]
A Phase 1 trial evaluating famitinib plus docetaxel in patients with advanced non-squamous non-small cell lung cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors [Phase 1]
A Phase 1 trial evaluating LY2584702 combined with erlotinib or everolimus in patients with solid tumors was terminated, and results have be…
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: SHR1020 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Squamous Non Small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating SHR1020 plus docetaxel versus placebo plus docetaxel in second-line non-squamous non-small cell lung cancer has b…
-
CLINICAL_TRIALS trial_result · 2019-01-17Clinical Trial Update: Docetaxel and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Has Been Completely Removed By Surgery [Phase 2]
This Phase 2 trial evaluates adjuvant docetaxel and cisplatin in patients with stage I-III non-small cell lung cancer completely removed by …
-
CLINICAL_TRIALS trial_result · 2019-01-17Clinical Trial Update: LDK378 in Adult Chinese Patients With ALK-rearranged (ALK-positive) Advanced Non-small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib [Phase 1, Phase 2]
Phase 1/2 results for LDK378 (alectinib) in adult Chinese patients with ALK-rearranged advanced non-small cell lung cancer who were previous…
-
CLINICAL_TRIALS trial_result · 2019-01-17Clinical Trial Update: Efficacy and Safety of SCT200 in Patients With Advanced Squamous Non-small Cell Lung Cancer [Phase 1]
Phase 1 trial update evaluating the preliminary efficacy and safety of SCT200 in patients with advanced squamous non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2019-01-17Clinical Trial Update: NY-ESO-1 TCR （TAEST16001）for Patients With Advanced NSCLC [Phase 1]
This document provides a Phase 1 clinical trial update for TAEST16001 NY-ESO-1–targeted T-cell receptor therapy in patients with advanced no…
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer [Phase 4]
Phase 4 trial evaluating the combination of zoledronic acid and radiotherapy for bone metastases in non-small cell lung cancer.